Unique Pharmaceutical, Ltd

FDA Regulatory Profile

Unique Pharmaceutical, Ltd appears in FDA public data with 3 recalls — including 1 Class I (most serious) —, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0012-2015, Class II) was initiated on July 18, 2014.

Summary

Total Recalls
3 (1 Class I)
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0012-2015Class IIAll sterile products within expiryJuly 18, 2014
D-0011-2015Class IN-Acetyl Cysteine 20% 4 mL Vial Stock Code: 4133July 18, 2014
D-1587-2014Class IINORepinephrine 4 mg in 250 mL Sodium Chloride0.9%, For IV Use Only, Flexible Bag, Rx only, UNIQUE PHApril 17, 2013